Mortality data from included studies
| Reference (3–6 month follow up) | Early deaths (<30 days or hospital deaths) | Late deaths (⩾30 days or home deaths) | Overall deaths |
|---|---|---|---|
| Argenziano24 | 6/92 (6%) | 8/86 (9%) | 14/92 (15%) |
| Bagley25 | 3/55 (5%) | 3/52 (6%) | 6/55 (11%) |
| Bousamra26 | 3/45 (7%) | 2/42 (5%) | 5/45 (9%) |
| Criner27 | 0/3 (0%) | 0/3 (0%) | 0/3 (0%) |
| Daniel28 | 1/17 (6%) | 0/16 (0%) | 1/17 (6%) |
| Eugene29 | 1/44 (2%) | 11/43 (25%) | 12/44 (27%) |
| Eugene30 | 0/28 (0%) | 3/28 (11%) | 3/28 (11%) |
| Keller31 | 0/25 (0%) | 0/25 (0%) | 0/25 (0%) |
| Kotloff (MS)32 | 5/80 (6%) | 6/75 (8%) | 11/80(14%) |
| Kotloff (VATS)32 | 1/40 (2%) | 0/40 (0%) | 1/40 (2%) |
| Little33 | N/A | N/A | 3/55 (5%) |
| Miller34 | 3/53 (6%) | 2/50 (4%) | 5/53 (9%) |
| Sciurbia35 | 0/20 (0%) | 0/20 (0%) | 0/20 (0%) |
| Snell36 | 1/20 (5%) | 0/20 (0%) | 1/20 (5%) |
| Stammberger37 | 0/42 (0%) | 3/42 (7%) | 3/42 (7%) |
| Zenati38 | 0/35 (0%) | 0/35 (0%) | 0/35 (0%) |
| IQ range 2 year follow up | 0–6% | 0–8% | 0–11% |
| Cooper39 | 6/150 (4%)2-150 | 4/144 (3%)2-150 | 10/150 (7%) |
| Cordova40 | 0/25 (0%) | 0/25 (0%) | 0/25 (0%) |
↵2-150 Deaths measured up to and after 90 days.
VATS = video assisted thoracic surgery; MS = median sternotomy.